首页 | 本学科首页   官方微博 | 高级检索  
     


Primary malignant tumours of the bone
Authors:Vaiyapuri P. SumathiLee Jeys  Anna Darbyshire
Affiliation:Vaiyapuri P Sumathi MBBS MD FRCPath is a Consultant Histopathologist at the Royal Orthopaedic Hospital, Birmingham, UK. Conflicts of interest: none declared; Lee Jeys MB ChB MSc (OrthEng) FRCS (Tr&Orth) is a Consultant Orthopaedic Oncology Surgeon at the Royal Orthopaedic Hospital, Birmingham, UK. Conflicts of interest: none declared; Anna Darbyshire BSc (Hons) is a Medical Student at the University of Southampton, UK
Abstract:Primary bone tumours are rare, with approximately 400 new cases per year in the UK. The diagnosis of bone tumours are hampered by delays in presentation. Radiographic changes are often characteristic for each type of bone tumour and should alert the physician to investigate further. Investigations should include blood tests, local staging and systemic staging. MRI, CT of the chest and isotope bone scans are important in evaluating the tumour. The most common types of bone tumour are osteosarcoma, chondrosarcoma, Ewing sarcoma, spindle cell sarcoma of bone and chordoma. The important pathological features and treatment of each type of tumour are described in this article. Early contact to a supra-regional bone tumour unit is mandatory when a bone tumour is suspected, where a multidisciplinary team approach is employed for an accurate diagnosis and appropriate management. Biopsy and surgical treatment should only be undertaken in such a unit and all patients should be enrolled in international clinical trials, where feasible, to gather data that will ultimately improve outcomes. The survival rates from most bone tumours are of the order of 60–80% with appropriate treatment.
Keywords:Chondrosarcoma   chordoma   Ewing   osteosarcoma   primary bone tumour
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号